FDA Inspection 1301968 — Vaughn, Silverberg, and Associates, LLP

Vaughn, Silverberg, and Associates, LLP — FEI 3011009880

The FDA completed an inspection of Vaughn, Silverberg, and Associates, LLP on February 4, 2026 in San Antonio, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
February 4, 2026
Fiscal Year
2026
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
San Antonio, TX (United States)